Risk of Melanoma and Non-Melanoma Skin Cancer in Patients with Psoriasis and Psoriatic Arthritis Treated with Targeted Therapies: A Systematic Review and Meta-Analysis

Risk of Melanoma and Non-Melanoma Skin Cancer in Patients with Psoriasis and Psoriatic Arthritis Treated with Targeted Therapies: A Systematic Review and Meta-Analysis

Targeted therapies represent major advancements in the treatment of chronic skin conditions such as psoriasis. While previous studies have shown an increased risk of melanoma and non-melanoma skin cancer (NMSC) in patients receiving TNF-α inhibitors, the risks associated with newer biologics (IL-12/...

Full description

Bibliographic Details
Main Authors: Marta Krzysztofik, Paweł Brzewski, Przemysław Cuber, Artur Kacprzyk, Aleksandra Kulbat, Karolina Richter, Tomasz Wojewoda, Wojciech M. Wysocki
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Pharmaceuticals
Subjects:
psoriasis
psoriatic arthritis
melanoma
skin cancer
biologics
targeted therapies
Online Access:https://www.mdpi.com/1424-8247/17/1/14

Internet

https://www.mdpi.com/1424-8247/17/1/14

Similar Items